ADVERTISEMENTs
Brooks-led study could improve HIV treatment of trans women in India
The research team, including scholars from Brown University and members of The Humsafar Trust, argues that interventions must integrate economic support, stigma reduction, and gender-affirming care to be truly effective.
A new study published in Global Public Health authored by William Lodge II, assistant professor in the Cornell Brooks School of Public Policy, suggests that a health policy approach that addresses economic barriers and social stigma and emphasizes individual and collective empowerment can be effective in expanding the adoption and success of free antiretroviral therapy (ART) among transgender women. / Cornell Chronicle
A new study published in Global Public Health has found that transgender women in India are nearly 20 times more likely to contract HIV than the national average, yet their access to life-saving antiretroviral therapy (ART) remains severely limited.
Despite the country’s ambitious “test and treat” program, which provides free ART upon diagnosis, the study highlights how structural barriers such as economic hardship, stigma, and lack of gender-affirming care, are preventing many transgender women from adhering to treatment.
This post is for paying subscribers only
SUBSCRIBE NOWADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
E Paper
ADVERTISEMENT
.jpg)
Video
.jpeg)
.jpeg)
.jpeg)
.jpeg)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login